Effects of signal regulatory proteinalpha1 on proliferation of hepatocellular carcinoma: a preliminary study
Jian-Min Qin1, He-Xin Yan, Xing-Wang Wan
1International Cooperative Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China. jianminqin@yahoo.com
Background:
Signal regulatory protein alpha1 (Sirpalpha1) is a negative regulatory factor, and inhibits receptor tyrosine kinase-dependent cell proliferating signal. This study was undertaken to observe the effect of signal regulatory proteinalpha1 (Sirpalpha1)on gankyrin,cyclin D1,CDK4 and Fas expression in Sk-hep1 mouse hepatoma carcinoma cell line.
Methods:
BOSC 23 packed cells were respectively transfected by means of recombinated retrovirus including pLXSN, pLXSN- Sirpalpha1 and pLXSN- Sirpalpha1P4Y2 with lipofectin, and various plasmid virus media(viral titer 2.1X10(6) CFU/ml) were collected and infected respectively in 80% confluent Sk-hep1 cells. Transfected Sk-hep1 cells were selectively screened with G418 (1200 mug/ml), and Sk-hep1 cell lines transfected with various plasmids were obtained. The protein expressions of gankyrin, cyclin D1, CDK4 and Fas in various Sk-hep1 lines were determined by Western blotting. Various Sk-hep1 lines were recovered to culture with 10% fetal bovine serum at 12 hours and 24 hours after starving culture with free serum for 72 hours, and cells were collected to determine the percentage of S phase cells of proliferating cycle by flow cytometry.
Results:
Sirpalpha1 transfection remarkably downregulated gankyrin and cyclin D1 expression. Sirpalpha1P4Y2 downregulation of gankyrin expression was greater than that of Sirpalpha1 (P<0.05), but no significant effect of Sirpalpha1 and Sirpalpha1P4Y2 on CDK4 and Fas protein expression was observed in transfected Sk-hep1 lines (P>0.05). The percentage of S phase cells significantly decreased in Sk-hep1 cells transfected with Sirpalpha1 and Sirpalpha1P4Y2 plasmids (vs pLXSN Sk-hep1, P<0.05). The percentage of S phase cells in various Sk-hep1 cells increased when recovering to culture with 10% fetal bovine serum at 12 hours, but the percentage of S phase cells in Sk-hep1 cells transfected with Sirpalpha1 was the lowest (vs pLXSN and Sirpalpha1P4Y2 Sk-hep1, P<0.05). The percentage of S phase cells in transfected pLSXN Sk-hep1 cells was the largest (vs Sirpalpha1 and Sirpalpha1P4Y2 Sk-hep1, P<0.05). There was no significant difference between the transfected Sirpalpha1 Sk-hep1 cells and Sirpalpha1P4Y2 Sk-hep1 cells (P>0.05).
Conclusions:
Sirpalpha1 decreases gankyrin and cyclin D1 expression, and inhibits proliferation of liver carcinoma cells. It may be one of the forms for an Sirpalpha1 negative regulation of carcinogenesis and development of hepatocellular carcinoma.
Insights
Signal regulatory protein alpha1 (Sirpalpha1) inhibits liver cancer cell proliferation by downregulating gankyrin and cyclin D1. This suggests Sirpalpha1 plays a role in suppressing hepatocellular carcinoma development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Signal regulatory protein alpha1 (Sirpalpha1) acts as a negative regulator, inhibiting receptor tyrosine kinase-dependent cell proliferation.
- Understanding Sirpalpha1's role in liver cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the effect of Sirpalpha1 on gankyrin, cyclin D1, CDK4, and Fas expression in Sk-hep1 mouse hepatoma cells.
- To assess Sirpalpha1's impact on the proliferation of liver carcinoma cells.
Main Methods:
- Transfection of Sk-hep1 cells with pLXSN, pLXSN-Sirpalpha1, and pLXSN-Sirpalpha1P4Y2 retroviral plasmids.
- Western blotting to determine protein expression levels of gankyrin, cyclin D1, CDK4, and Fas.
- Flow cytometry to analyze the percentage of S-phase cells in the cell cycle.
Main Results:
- Sirpalpha1 transfection significantly downregulated gankyrin and cyclin D1 expression.
- Sirpalpha1 and Sirpalpha1P4Y2 transfection led to a significant decrease in the percentage of S-phase cells, indicating reduced proliferation.
- No significant effect of Sirpalpha1 or Sirpalpha1P4Y2 on CDK4 and Fas protein expression was observed.
Conclusions:
- Sirpalpha1 effectively decreases gankyrin and cyclin D1 expression, thereby inhibiting liver carcinoma cell proliferation.
- Sirpalpha1 demonstrates potential as a negative regulator in the carcinogenesis and development of hepatocellular carcinoma.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:23Abnormal Proliferation
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...